Suchilactone
CAS No. 50816-74-5
Suchilactone( —— )
Catalog No. M31506 CAS No. 50816-74-5
Suchilactone may have the potential to be developed as a treatment of Alzheimer's Disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 486 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSuchilactone
-
NoteResearch use only, not for human use.
-
Brief DescriptionSuchilactone may have the potential to be developed as a treatment of Alzheimer's Disease.
-
DescriptionSuchilactone may have the potential to be developed as a treatment of Alzheimer's Disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number50816-74-5
-
Formula Weight368.4
-
Molecular FormulaC21H20O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Pentadecanoic acid
Pentadecylic acid is a saturated fatty acid with a 15-carbon backbone.
-
Angiotensin I/II 1-5
Angiotensin I/II (1-5) is a peptide (ASP-ARG-VAL-TYR-ILE) that contains the amino acids 1-5 and is converted from Angiotensin I/II.
-
Atracurium besylate
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
Cart
sales@molnova.com